nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—prostate cancer	0.834	1	CbGaD
Pralidoxime—Inflammation—Degarelix—prostate cancer	0.00291	0.0374	CcSEcCtD
Pralidoxime—Muscular weakness—Degarelix—prostate cancer	0.00181	0.0232	CcSEcCtD
Pralidoxime—Drowsiness—Flutamide—prostate cancer	0.00176	0.0226	CcSEcCtD
Pralidoxime—Inflammation—Conjugated Estrogens—prostate cancer	0.00162	0.0208	CcSEcCtD
Pralidoxime—Muscular weakness—Bicalutamide—prostate cancer	0.00146	0.0188	CcSEcCtD
Pralidoxime—Inflammation—Estradiol—prostate cancer	0.0013	0.0167	CcSEcCtD
Pralidoxime—Vision blurred—Degarelix—prostate cancer	0.00116	0.0149	CcSEcCtD
Pralidoxime—Haemoglobin—Bicalutamide—prostate cancer	0.00115	0.0148	CcSEcCtD
Pralidoxime—Haemorrhage—Bicalutamide—prostate cancer	0.00114	0.0147	CcSEcCtD
Pralidoxime—Pain—Estrone—prostate cancer	0.00104	0.0133	CcSEcCtD
Pralidoxime—Inflammation—Etoposide—prostate cancer	0.001	0.0129	CcSEcCtD
Pralidoxime—Somnolence—Flutamide—prostate cancer	0.000997	0.0128	CcSEcCtD
Pralidoxime—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.000973	0.0125	CcSEcCtD
Pralidoxime—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000968	0.0124	CcSEcCtD
Pralidoxime—Pain—Nilutamide—prostate cancer	0.000963	0.0124	CcSEcCtD
Pralidoxime—Tachycardia—Cabazitaxel—prostate cancer	0.000925	0.0119	CcSEcCtD
Pralidoxime—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000905	0.0116	CcSEcCtD
Pralidoxime—Drowsiness—Goserelin—prostate cancer	0.000887	0.0114	CcSEcCtD
Pralidoxime—Pain—Degarelix—prostate cancer	0.000861	0.0111	CcSEcCtD
Pralidoxime—Inflammation—Docetaxel—prostate cancer	0.000835	0.0107	CcSEcCtD
Pralidoxime—Pain—Cabazitaxel—prostate cancer	0.000811	0.0104	CcSEcCtD
Pralidoxime—Inflammation—Capecitabine—prostate cancer	0.000808	0.0104	CcSEcCtD
Pralidoxime—Dizziness—Estrone—prostate cancer	0.000802	0.0103	CcSEcCtD
Pralidoxime—Haemoglobin—Goserelin—prostate cancer	0.0008	0.0103	CcSEcCtD
Pralidoxime—Haemorrhage—Goserelin—prostate cancer	0.000796	0.0102	CcSEcCtD
Pralidoxime—Headache—Estramustine—prostate cancer	0.000795	0.0102	CcSEcCtD
Pralidoxime—Hyperventilation—Epirubicin—prostate cancer	0.000794	0.0102	CcSEcCtD
Pralidoxime—Headache—Estrone—prostate cancer	0.00076	0.00977	CcSEcCtD
Pralidoxime—Nausea—Estramustine—prostate cancer	0.000754	0.00969	CcSEcCtD
Pralidoxime—Dizziness—Nilutamide—prostate cancer	0.000745	0.00957	CcSEcCtD
Pralidoxime—Dizziness—Flutamide—prostate cancer	0.000742	0.00953	CcSEcCtD
Pralidoxime—Hyperventilation—Doxorubicin—prostate cancer	0.000734	0.00944	CcSEcCtD
Pralidoxime—Somnolence—Bicalutamide—prostate cancer	0.000723	0.00929	CcSEcCtD
Pralidoxime—Nausea—Estrone—prostate cancer	0.00072	0.00926	CcSEcCtD
Pralidoxime—Headache—Nilutamide—prostate cancer	0.000706	0.00907	CcSEcCtD
Pralidoxime—Headache—Flutamide—prostate cancer	0.000703	0.00903	CcSEcCtD
Pralidoxime—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.0007	0.009	CcSEcCtD
Pralidoxime—Pain—Bicalutamide—prostate cancer	0.000696	0.00894	CcSEcCtD
Pralidoxime—Nausea—Nilutamide—prostate cancer	0.000669	0.0086	CcSEcCtD
Pralidoxime—Nausea—Flutamide—prostate cancer	0.000666	0.00856	CcSEcCtD
Pralidoxime—Dizziness—Degarelix—prostate cancer	0.000666	0.00855	CcSEcCtD
Pralidoxime—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000663	0.00852	CcSEcCtD
Pralidoxime—Drowsiness—Mitoxantrone—prostate cancer	0.000655	0.00842	CcSEcCtD
Pralidoxime—Vision blurred—Goserelin—prostate cancer	0.000653	0.0084	CcSEcCtD
Pralidoxime—Vision blurred—Conjugated Estrogens—prostate cancer	0.000647	0.00832	CcSEcCtD
Pralidoxime—Haemoglobin—Estradiol—prostate cancer	0.000635	0.00815	CcSEcCtD
Pralidoxime—Haemorrhage—Estradiol—prostate cancer	0.000631	0.00811	CcSEcCtD
Pralidoxime—Headache—Degarelix—prostate cancer	0.00063	0.0081	CcSEcCtD
Pralidoxime—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000629	0.00808	CcSEcCtD
Pralidoxime—Dizziness—Cabazitaxel—prostate cancer	0.000627	0.00806	CcSEcCtD
Pralidoxime—Nausea—Degarelix—prostate cancer	0.000598	0.00768	CcSEcCtD
Pralidoxime—Headache—Cabazitaxel—prostate cancer	0.000594	0.00763	CcSEcCtD
Pralidoxime—Haemoglobin—Mitoxantrone—prostate cancer	0.000591	0.0076	CcSEcCtD
Pralidoxime—Haemorrhage—Mitoxantrone—prostate cancer	0.000588	0.00756	CcSEcCtD
Pralidoxime—Diplopia—Capecitabine—prostate cancer	0.000569	0.00731	CcSEcCtD
Pralidoxime—Nausea—Cabazitaxel—prostate cancer	0.000563	0.00724	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—prostate cancer	0.000563	0.00724	CcSEcCtD
Pralidoxime—Tachycardia—Goserelin—prostate cancer	0.000552	0.0071	CcSEcCtD
Pralidoxime—Tachycardia—Conjugated Estrogens—prostate cancer	0.000547	0.00703	CcSEcCtD
Pralidoxime—Dizziness—Bicalutamide—prostate cancer	0.000538	0.00691	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—prostate cancer	0.000521	0.0067	CcSEcCtD
Pralidoxime—Headache—Bicalutamide—prostate cancer	0.00051	0.00655	CcSEcCtD
Pralidoxime—Agitation—Estradiol—prostate cancer	0.000505	0.00649	CcSEcCtD
Pralidoxime—Somnolence—Goserelin—prostate cancer	0.000503	0.00646	CcSEcCtD
Pralidoxime—Muscular weakness—Capecitabine—prostate cancer	0.000502	0.00645	CcSEcCtD
Pralidoxime—Somnolence—Conjugated Estrogens—prostate cancer	0.000498	0.0064	CcSEcCtD
Pralidoxime—Pain—Goserelin—prostate cancer	0.000484	0.00622	CcSEcCtD
Pralidoxime—Nausea—Bicalutamide—prostate cancer	0.000483	0.00621	CcSEcCtD
Pralidoxime—Vision blurred—Mitoxantrone—prostate cancer	0.000483	0.0062	CcSEcCtD
Pralidoxime—Pain—Conjugated Estrogens—prostate cancer	0.000479	0.00616	CcSEcCtD
Pralidoxime—Dizziness—Ethinyl Estradiol—prostate cancer	0.000455	0.00584	CcSEcCtD
Pralidoxime—Muscular weakness—Prednisone—prostate cancer	0.000447	0.00575	CcSEcCtD
Pralidoxime—Tachycardia—Estradiol—prostate cancer	0.000438	0.00563	CcSEcCtD
Pralidoxime—Headache—Ethinyl Estradiol—prostate cancer	0.000431	0.00553	CcSEcCtD
Pralidoxime—Haemoglobin—Docetaxel—prostate cancer	0.000409	0.00525	CcSEcCtD
Pralidoxime—Nausea—Ethinyl Estradiol—prostate cancer	0.000408	0.00525	CcSEcCtD
Pralidoxime—Tachycardia—Mitoxantrone—prostate cancer	0.000408	0.00524	CcSEcCtD
Pralidoxime—Haemorrhage—Docetaxel—prostate cancer	0.000407	0.00523	CcSEcCtD
Pralidoxime—Somnolence—Estradiol—prostate cancer	0.000399	0.00512	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—prostate cancer	0.000396	0.0051	CcSEcCtD
Pralidoxime—Haemoglobin—Capecitabine—prostate cancer	0.000396	0.00509	CcSEcCtD
Pralidoxime—Haemorrhage—Capecitabine—prostate cancer	0.000394	0.00506	CcSEcCtD
Pralidoxime—Pain—Estradiol—prostate cancer	0.000384	0.00493	CcSEcCtD
Pralidoxime—Dizziness—Goserelin—prostate cancer	0.000374	0.00481	CcSEcCtD
Pralidoxime—Somnolence—Mitoxantrone—prostate cancer	0.000372	0.00477	CcSEcCtD
Pralidoxime—Dizziness—Conjugated Estrogens—prostate cancer	0.000371	0.00476	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—prostate cancer	0.000367	0.00471	CcSEcCtD
Pralidoxime—Pain—Mitoxantrone—prostate cancer	0.000357	0.00459	CcSEcCtD
Pralidoxime—Headache—Goserelin—prostate cancer	0.000354	0.00456	CcSEcCtD
Pralidoxime—Haemoglobin—Prednisone—prostate cancer	0.000352	0.00453	CcSEcCtD
Pralidoxime—Headache—Conjugated Estrogens—prostate cancer	0.000351	0.00451	CcSEcCtD
Pralidoxime—Haemorrhage—Prednisone—prostate cancer	0.000351	0.00451	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—prostate cancer	0.00035	0.00449	CcSEcCtD
Pralidoxime—Tachycardia—Etoposide—prostate cancer	0.000339	0.00436	CcSEcCtD
Pralidoxime—Nausea—Goserelin—prostate cancer	0.000336	0.00432	CcSEcCtD
Pralidoxime—Nausea—Conjugated Estrogens—prostate cancer	0.000333	0.00428	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—prostate cancer	0.000324	0.00416	CcSEcCtD
Pralidoxime—Vision blurred—Capecitabine—prostate cancer	0.000323	0.00415	CcSEcCtD
Pralidoxime—Somnolence—Etoposide—prostate cancer	0.000309	0.00397	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—prostate cancer	0.000306	0.00393	CcSEcCtD
Pralidoxime—Pain—Etoposide—prostate cancer	0.000297	0.00382	CcSEcCtD
Pralidoxime—Dizziness—Estradiol—prostate cancer	0.000297	0.00381	CcSEcCtD
Pralidoxime—Vision blurred—Prednisone—prostate cancer	0.000288	0.0037	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—prostate cancer	0.000283	0.00363	CcSEcCtD
Pralidoxime—Tachycardia—Docetaxel—prostate cancer	0.000282	0.00362	CcSEcCtD
Pralidoxime—Headache—Estradiol—prostate cancer	0.000281	0.00361	CcSEcCtD
Pralidoxime—Agitation—Prednisone—prostate cancer	0.000281	0.00361	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—prostate cancer	0.000276	0.00354	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—prostate cancer	0.000274	0.00352	CcSEcCtD
Pralidoxime—Tachycardia—Capecitabine—prostate cancer	0.000273	0.00351	CcSEcCtD
Pralidoxime—Nausea—Estradiol—prostate cancer	0.000266	0.00342	CcSEcCtD
Pralidoxime—Headache—Mitoxantrone—prostate cancer	0.000262	0.00336	CcSEcCtD
Pralidoxime—Somnolence—Docetaxel—prostate cancer	0.000257	0.0033	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—prostate cancer	0.000255	0.00328	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—prostate cancer	0.000254	0.00326	CcSEcCtD
Pralidoxime—Nausea—Mitoxantrone—prostate cancer	0.000248	0.00319	CcSEcCtD
Pralidoxime—Pain—Docetaxel—prostate cancer	0.000247	0.00317	CcSEcCtD
Pralidoxime—Tachycardia—Prednisone—prostate cancer	0.000243	0.00312	CcSEcCtD
Pralidoxime—Pain—Capecitabine—prostate cancer	0.000239	0.00307	CcSEcCtD
Pralidoxime—Dizziness—Etoposide—prostate cancer	0.00023	0.00295	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—prostate cancer	0.000225	0.00289	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—prostate cancer	0.000219	0.00282	CcSEcCtD
Pralidoxime—Headache—Etoposide—prostate cancer	0.000218	0.0028	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—prostate cancer	0.000208	0.00268	CcSEcCtD
Pralidoxime—Nausea—Etoposide—prostate cancer	0.000206	0.00265	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—prostate cancer	0.000203	0.00261	CcSEcCtD
Pralidoxime—Dizziness—Docetaxel—prostate cancer	0.000191	0.00246	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—prostate cancer	0.00019	0.00244	CcSEcCtD
Pralidoxime—Dizziness—Capecitabine—prostate cancer	0.000185	0.00238	CcSEcCtD
Pralidoxime—Headache—Docetaxel—prostate cancer	0.000181	0.00233	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—prostate cancer	0.000176	0.00226	CcSEcCtD
Pralidoxime—Headache—Capecitabine—prostate cancer	0.000175	0.00225	CcSEcCtD
Pralidoxime—Somnolence—Epirubicin—prostate cancer	0.000173	0.00223	CcSEcCtD
Pralidoxime—Nausea—Docetaxel—prostate cancer	0.000172	0.00221	CcSEcCtD
Pralidoxime—Pain—Epirubicin—prostate cancer	0.000167	0.00214	CcSEcCtD
Pralidoxime—Nausea—Capecitabine—prostate cancer	0.000166	0.00214	CcSEcCtD
Pralidoxime—Dizziness—Prednisone—prostate cancer	0.000165	0.00212	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—prostate cancer	0.00016	0.00206	CcSEcCtD
Pralidoxime—Headache—Prednisone—prostate cancer	0.000156	0.00201	CcSEcCtD
Pralidoxime—Pain—Doxorubicin—prostate cancer	0.000154	0.00198	CcSEcCtD
Pralidoxime—Nausea—Prednisone—prostate cancer	0.000148	0.0019	CcSEcCtD
Pralidoxime—Dizziness—Epirubicin—prostate cancer	0.000129	0.00166	CcSEcCtD
Pralidoxime—Headache—Epirubicin—prostate cancer	0.000122	0.00157	CcSEcCtD
Pralidoxime—Dizziness—Doxorubicin—prostate cancer	0.000119	0.00153	CcSEcCtD
Pralidoxime—Nausea—Epirubicin—prostate cancer	0.000116	0.00149	CcSEcCtD
Pralidoxime—Headache—Doxorubicin—prostate cancer	0.000113	0.00145	CcSEcCtD
Pralidoxime—Nausea—Doxorubicin—prostate cancer	0.000107	0.00138	CcSEcCtD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	7.67e-05	0.000868	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	7.67e-05	0.000868	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—B4GALT4—prostate cancer	7.66e-05	0.000867	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPGD—prostate cancer	7.66e-05	0.000867	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGFBP3—prostate cancer	7.61e-05	0.000862	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	7.56e-05	0.000856	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PTEN—prostate cancer	7.46e-05	0.000845	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	7.4e-05	0.000837	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MDM2—prostate cancer	7.39e-05	0.000837	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	7.38e-05	0.000835	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	7.34e-05	0.00083	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	7.26e-05	0.000822	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATF3—prostate cancer	7.22e-05	0.000817	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TNFRSF21—prostate cancer	7.21e-05	0.000816	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS19—prostate cancer	7.14e-05	0.000809	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTSD—prostate cancer	7.03e-05	0.000796	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP7B1—prostate cancer	7.01e-05	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTAP—prostate cancer	7.01e-05	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	7e-05	0.000793	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—THBS1—prostate cancer	6.93e-05	0.000784	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.92e-05	0.000783	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	6.86e-05	0.000777	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	6.85e-05	0.000775	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPGD—prostate cancer	6.84e-05	0.000774	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—B4GALT4—prostate cancer	6.84e-05	0.000774	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SULT1E1—prostate cancer	6.83e-05	0.000773	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SRD5A1—prostate cancer	6.83e-05	0.000773	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGFBP3—prostate cancer	6.79e-05	0.000769	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	6.68e-05	0.000756	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	6.64e-05	0.000751	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACHE—prostate cancer	6.63e-05	0.00075	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	6.62e-05	0.000749	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MDM2—prostate cancer	6.6e-05	0.000747	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CALR—prostate cancer	6.58e-05	0.000745	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	6.54e-05	0.00074	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD17B3—prostate cancer	6.52e-05	0.000738	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ACSL4—prostate cancer	6.52e-05	0.000738	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	6.46e-05	0.000732	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	6.45e-05	0.00073	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	6.44e-05	0.000729	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TNFRSF21—prostate cancer	6.43e-05	0.000728	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS19—prostate cancer	6.37e-05	0.000721	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTSD—prostate cancer	6.27e-05	0.00071	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACE—prostate cancer	6.27e-05	0.00071	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP7B1—prostate cancer	6.25e-05	0.000708	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTAP—prostate cancer	6.25e-05	0.000708	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ARG2—prostate cancer	6.25e-05	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UMPS—prostate cancer	6.25e-05	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PHGDH—prostate cancer	6.25e-05	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	6.22e-05	0.000704	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—THBS1—prostate cancer	6.18e-05	0.0007	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	6.15e-05	0.000696	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LDHB—prostate cancer	6.13e-05	0.000694	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	6.11e-05	0.000692	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SULT1E1—prostate cancer	6.09e-05	0.00069	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SRD5A1—prostate cancer	6.09e-05	0.00069	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP3A5—prostate cancer	6.01e-05	0.000681	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	5.98e-05	0.000677	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.92e-05	0.00067	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—prostate cancer	5.9e-05	0.000668	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CALR—prostate cancer	5.87e-05	0.000665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.83e-05	0.00066	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	5.83e-05	0.000659	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD17B3—prostate cancer	5.81e-05	0.000658	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACSL4—prostate cancer	5.81e-05	0.000658	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TCN2—prostate cancer	5.81e-05	0.000657	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UCP3—prostate cancer	5.81e-05	0.000657	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PDHA1—prostate cancer	5.81e-05	0.000657	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA3—prostate cancer	5.81e-05	0.000657	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.75e-05	0.00065	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MDM2—prostate cancer	5.66e-05	0.000641	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLAUR—prostate cancer	5.63e-05	0.000637	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACE—prostate cancer	5.59e-05	0.000633	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ARG2—prostate cancer	5.57e-05	0.000631	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UMPS—prostate cancer	5.57e-05	0.000631	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PHGDH—prostate cancer	5.57e-05	0.000631	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.55e-05	0.000628	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC22A3—prostate cancer	5.54e-05	0.000627	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD3B1—prostate cancer	5.54e-05	0.000627	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LDHB—prostate cancer	5.47e-05	0.000619	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.38e-05	0.000609	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP3A5—prostate cancer	5.37e-05	0.000607	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	5.36e-05	0.000607	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.35e-05	0.000605	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA4—prostate cancer	5.31e-05	0.000601	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TBXAS1—prostate cancer	5.31e-05	0.000601	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—prostate cancer	5.26e-05	0.000596	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.24e-05	0.000593	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.19e-05	0.000588	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PDHA1—prostate cancer	5.18e-05	0.000587	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UCP3—prostate cancer	5.18e-05	0.000587	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TCN2—prostate cancer	5.18e-05	0.000587	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA3—prostate cancer	5.18e-05	0.000587	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA2—prostate cancer	5.18e-05	0.000586	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG5—prostate cancer	5.11e-05	0.000579	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SULT1A1—prostate cancer	5.11e-05	0.000579	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MDM2—prostate cancer	5.05e-05	0.000572	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLAUR—prostate cancer	5.02e-05	0.000569	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTA1—prostate cancer	5e-05	0.000565	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	4.95e-05	0.00056	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD3B1—prostate cancer	4.94e-05	0.00056	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC22A3—prostate cancer	4.94e-05	0.00056	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD3B2—prostate cancer	4.94e-05	0.000559	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTO1—prostate cancer	4.94e-05	0.000559	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NAT2—prostate cancer	4.94e-05	0.000559	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.8e-05	0.000543	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.75e-05	0.000538	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TBXAS1—prostate cancer	4.74e-05	0.000536	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA4—prostate cancer	4.74e-05	0.000536	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LRP2—prostate cancer	4.74e-05	0.000536	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2C18—prostate cancer	4.74e-05	0.000536	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLCB2—prostate cancer	4.74e-05	0.000536	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—P4HB—prostate cancer	4.64e-05	0.000526	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.63e-05	0.000524	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA2—prostate cancer	4.62e-05	0.000523	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG5—prostate cancer	4.56e-05	0.000516	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SULT1A1—prostate cancer	4.56e-05	0.000516	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	4.55e-05	0.000515	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC22A1—prostate cancer	4.52e-05	0.000511	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.47e-05	0.000505	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTA1—prostate cancer	4.46e-05	0.000504	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NAT2—prostate cancer	4.41e-05	0.000499	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD3B2—prostate cancer	4.41e-05	0.000499	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTO1—prostate cancer	4.41e-05	0.000499	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SULT2A1—prostate cancer	4.4e-05	0.000498	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.4e-05	0.000498	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MED12—prostate cancer	4.33e-05	0.00049	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GNG5—prostate cancer	4.3e-05	0.000486	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.24e-05	0.00048	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLCB2—prostate cancer	4.22e-05	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LRP2—prostate cancer	4.22e-05	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2C18—prostate cancer	4.22e-05	0.000478	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—P4HB—prostate cancer	4.14e-05	0.000469	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA3—prostate cancer	4.14e-05	0.000468	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.07e-05	0.00046	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC22A1—prostate cancer	4.03e-05	0.000456	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.98e-05	0.000451	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HPGDS—prostate cancer	3.95e-05	0.000447	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SULT2A1—prostate cancer	3.93e-05	0.000444	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2C19—prostate cancer	3.92e-05	0.000444	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LEP—prostate cancer	3.89e-05	0.000441	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MED12—prostate cancer	3.86e-05	0.000437	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GNG5—prostate cancer	3.83e-05	0.000434	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTT1—prostate cancer	3.83e-05	0.000433	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2A6—prostate cancer	3.79e-05	0.000428	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.77e-05	0.000427	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.72e-05	0.000421	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA3—prostate cancer	3.69e-05	0.000418	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKR1C3—prostate cancer	3.68e-05	0.000417	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PRKACB—prostate cancer	3.66e-05	0.000415	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.63e-05	0.000411	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP17A1—prostate cancer	3.63e-05	0.00041	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.58e-05	0.000405	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HPGDS—prostate cancer	3.52e-05	0.000399	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2C19—prostate cancer	3.5e-05	0.000396	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LEP—prostate cancer	3.47e-05	0.000393	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA2—prostate cancer	3.45e-05	0.000391	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTT1—prostate cancer	3.42e-05	0.000387	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACHE—prostate cancer	3.42e-05	0.000387	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2A6—prostate cancer	3.38e-05	0.000382	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.36e-05	0.000381	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—INS—prostate cancer	3.33e-05	0.000377	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC5A5—prostate cancer	3.3e-05	0.000373	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKR1C3—prostate cancer	3.29e-05	0.000372	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PRKACB—prostate cancer	3.27e-05	0.00037	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP17A1—prostate cancer	3.23e-05	0.000366	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2E1—prostate cancer	3.22e-05	0.000364	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—prostate cancer	3.22e-05	0.000364	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.19e-05	0.000361	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NQO1—prostate cancer	3.18e-05	0.00036	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TH—prostate cancer	3.14e-05	0.000355	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.12e-05	0.000353	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—prostate cancer	3.11e-05	0.000352	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP3A4—prostate cancer	3.1e-05	0.000351	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.09e-05	0.000349	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA2—prostate cancer	3.08e-05	0.000349	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1B1—prostate cancer	3.05e-05	0.000345	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—INS—prostate cancer	2.97e-05	0.000336	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GGT1—prostate cancer	2.96e-05	0.000334	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC5A5—prostate cancer	2.94e-05	0.000333	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA1—prostate cancer	2.91e-05	0.000329	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2E1—prostate cancer	2.87e-05	0.000325	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—prostate cancer	2.87e-05	0.000325	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP19A1—prostate cancer	2.87e-05	0.000325	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NQO1—prostate cancer	2.84e-05	0.000321	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TH—prostate cancer	2.8e-05	0.000317	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.78e-05	0.000315	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—prostate cancer	2.78e-05	0.000314	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP3A4—prostate cancer	2.77e-05	0.000313	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—RXRA—prostate cancer	2.77e-05	0.000313	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.75e-05	0.000312	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1B1—prostate cancer	2.72e-05	0.000308	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.69e-05	0.000305	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COMT—prostate cancer	2.67e-05	0.000302	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—prostate cancer	2.65e-05	0.0003	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GGT1—prostate cancer	2.64e-05	0.000298	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ITPR1—prostate cancer	2.61e-05	0.000296	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA1—prostate cancer	2.6e-05	0.000294	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—prostate cancer	2.59e-05	0.000293	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.57e-05	0.000291	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP19A1—prostate cancer	2.56e-05	0.00029	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—RXRA—prostate cancer	2.47e-05	0.00028	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TYMS—prostate cancer	2.47e-05	0.000279	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—prostate cancer	2.44e-05	0.000276	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.4e-05	0.000272	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPL—prostate cancer	2.39e-05	0.000271	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTNNB1—prostate cancer	2.39e-05	0.00027	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COMT—prostate cancer	2.38e-05	0.000269	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—prostate cancer	2.37e-05	0.000268	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ITPR1—prostate cancer	2.33e-05	0.000264	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP1A1—prostate cancer	2.31e-05	0.000262	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—prostate cancer	2.31e-05	0.000261	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ERCC2—prostate cancer	2.29e-05	0.00026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.29e-05	0.000259	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TYMS—prostate cancer	2.2e-05	0.000249	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—prostate cancer	2.18e-05	0.000246	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—prostate cancer	2.16e-05	0.000244	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPL—prostate cancer	2.14e-05	0.000242	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	2.13e-05	0.000241	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARA—prostate cancer	2.12e-05	0.000239	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP1A1—prostate cancer	2.06e-05	0.000233	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ERCC2—prostate cancer	2.05e-05	0.000232	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAV1—prostate cancer	1.99e-05	0.000225	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—prostate cancer	1.92e-05	0.000218	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.9e-05	0.000215	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARA—prostate cancer	1.89e-05	0.000214	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—prostate cancer	1.81e-05	0.000205	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAV1—prostate cancer	1.77e-05	0.000201	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INS—prostate cancer	1.71e-05	0.000194	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.69e-05	0.000192	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CREBBP—prostate cancer	1.68e-05	0.00019	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—prostate cancer	1.62e-05	0.000183	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CD—prostate cancer	1.59e-05	0.00018	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INS—prostate cancer	1.53e-05	0.000173	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—prostate cancer	1.5e-05	0.00017	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CREBBP—prostate cancer	1.5e-05	0.00017	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CD—prostate cancer	1.42e-05	0.000161	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CB—prostate cancer	1.39e-05	0.000157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—prostate cancer	1.38e-05	0.000156	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—prostate cancer	1.34e-05	0.000152	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CB—prostate cancer	1.24e-05	0.00014	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—prostate cancer	1.23e-05	0.000139	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTEN—prostate cancer	1.2e-05	0.000136	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—EP300—prostate cancer	1.14e-05	0.000129	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTEN—prostate cancer	1.07e-05	0.000121	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—EP300—prostate cancer	1.02e-05	0.000115	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—prostate cancer	8.46e-06	9.58e-05	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—prostate cancer	7.55e-06	8.54e-05	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—prostate cancer	6.91e-06	7.82e-05	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—prostate cancer	6.17e-06	6.98e-05	CbGpPWpGaD
